Spelling suggestions: "subject:"foam cells"" "subject:"foam wells""
1 |
The role of glycation and glycoxidation of low-density lipoproteins in foam cell formation.Brown, Bronnwyn Elizabeth January 2005 (has links)
People with diabetes suffer from an increased incidence of atherosclerosis, possibly due to the hyperglycaemia associated with this disease. Glucose may covalently modify proteins via glycation and glycoxidation reactions. Reactive aldehydes (e.g. methylglyoxal and glycolaldehyde) generated from these glycation and glycoxidation reactions, lipid peroxidation and other metabolic pathways may also modify proteins in glycation and glycoxidation reactions. These reactions can result in the formation of advanced glycation end-products, which are increased in diabetes and associated complications such as atherosclerosis. Low-density lipoproteins (LDLs) are the main source of lipid in atherosclerotic plaques, and the lipid-laden foam cells contained within. Modification of the single protein in LDL, apolipoprotein B-100 (apo B) by glucose and aldehydes may result in recognition of these altered LDL particles by macrophage scavenger receptors and cellular accumulation of cholesteryl esters; such accumulation is characteristic of atherosclerotic foam cells. The extent and nature of the modifications of LDLs that give rise to this behaviour have been poorly characterised, especially in regards to modification/oxidation of protein versus lipid components induced by glucose and low-molecular-mass aldehydes. Therefore the aims of this project were to: 1) characterise LDL modification by glucose, methylglyoxal and glycolaldehyde; 2) examine the effect of these modified LDLs on arterial cells by monitoring cellular viability, proliferation and cholesterol and cholesteryl ester levels; and 3) examine macrophage handling of apo B from these modified LDLs. Glycolaldehyde induced more rapid and more extensive changes to LDL than methylglyoxal, which was significantly more modified than LDL exposed to glucose, in the presence or absence of Cu2+. LDL was modified by glycolaldehyde and methylglyoxal in a time- and concentration-dependent manner. These aldehyde-modified LDLs were significantly more negatively charged relative (determined by changes in relative electrophoretic mobility), more aggregated (by SDS-PAGE) and lost more Arg, Lys and Trp residues (assessed by fluorescence-based assays) than glucose-modified and control LDLs. Glucose-modified LDL had more modest increases in net negative charge, aggregation and only significantly lost Arg residues. Under the conditions examined none of the modified LDLs contained significant levels of the protein oxidation products DOPA and o-tyrosine, the lipid oxidation products 7-ketocholesterol and cholesteryl ester hydro(pero)oxides, nor marked depletion of the major antioxidant α-tocopherol or significant radical formation (EPR spectroscopy). Therefore these LDLs were glycated, but not (glyc)oxidised, and so allowed the cellular uptake of glycated LDL, rather than glycoxidised LDL, to be examined. These glycated LDLs had no effect on the cellular viability (assessed by LDH release), cell protein (BCA assay), and cholesterol and cholesteryl ester levels (quantified by reverse-phase HPLC) of endothelial and smooth muscle cells. The glycated LDLs also had no effects on human and mouse macrophage viability, protein and free cholesterol levels. However, exposure of macrophages to some of the glycated LDLs resulted in significant accumulation of cholesteryl esters and apo B. The greatest cellular accumulation of cholesteryl esters was in cells exposed to glycolaldehyde-modified LDL, which occurred in a time- and concentration-dependent manner. Less cholesteryl ester accumulation was observed in cells exposed to methylglyoxal-modified LDL, but some conditions resulted in significantly more cellular cholesteryl esters as compared to control LDLs, unlike glucose-modified LDL. Macrophages endocytosed significantly more apo B from glycolaldehyde-modified LDL labelled with 125I on the apo B, than methylglyoxal-modified 125I-LDL. Apo B from methylglyoxal-modified 125I-LDL was also endocytosed and degraded in greater amounts than control 125I-LDLs, unlike glucose-modified 125I-LDLs. The glycation of LDL by some low-molecular-mass aldehydes have been shown to result in model foam cell formation as characterised by cholesteryl ester and apo B accumulation. This accumulation correlated with increases in net negative charge, aggregation and loss of Lys and Trp residues of the apo B in glycated LDL particles. However, the differences in cellular uptake of glycolaldehyde- versus methylglyoxal-modified LDL were not completely resolved and it is postulated that this may arise from the extent or type of products formed on key amino acid residues, resulting in differential uptake by macrophage scavenger receptors, rather than loss of particular amino acids per se. Therefore these studies provide a potential mechanism to explain the increased atherosclerosis in people with diabetes, and a suitable model to examine the potential inhibition of the effects of glycated LDLs. This could provide potential therapeutic interventions to reduce diabetes-induced atherosclerosis.
|
2 |
The role of glycation and glycoxidation of low-density lipoproteins in foam cell formation.Brown, Bronnwyn Elizabeth January 2005 (has links)
People with diabetes suffer from an increased incidence of atherosclerosis, possibly due to the hyperglycaemia associated with this disease. Glucose may covalently modify proteins via glycation and glycoxidation reactions. Reactive aldehydes (e.g. methylglyoxal and glycolaldehyde) generated from these glycation and glycoxidation reactions, lipid peroxidation and other metabolic pathways may also modify proteins in glycation and glycoxidation reactions. These reactions can result in the formation of advanced glycation end-products, which are increased in diabetes and associated complications such as atherosclerosis. Low-density lipoproteins (LDLs) are the main source of lipid in atherosclerotic plaques, and the lipid-laden foam cells contained within. Modification of the single protein in LDL, apolipoprotein B-100 (apo B) by glucose and aldehydes may result in recognition of these altered LDL particles by macrophage scavenger receptors and cellular accumulation of cholesteryl esters; such accumulation is characteristic of atherosclerotic foam cells. The extent and nature of the modifications of LDLs that give rise to this behaviour have been poorly characterised, especially in regards to modification/oxidation of protein versus lipid components induced by glucose and low-molecular-mass aldehydes. Therefore the aims of this project were to: 1) characterise LDL modification by glucose, methylglyoxal and glycolaldehyde; 2) examine the effect of these modified LDLs on arterial cells by monitoring cellular viability, proliferation and cholesterol and cholesteryl ester levels; and 3) examine macrophage handling of apo B from these modified LDLs. Glycolaldehyde induced more rapid and more extensive changes to LDL than methylglyoxal, which was significantly more modified than LDL exposed to glucose, in the presence or absence of Cu2+. LDL was modified by glycolaldehyde and methylglyoxal in a time- and concentration-dependent manner. These aldehyde-modified LDLs were significantly more negatively charged relative (determined by changes in relative electrophoretic mobility), more aggregated (by SDS-PAGE) and lost more Arg, Lys and Trp residues (assessed by fluorescence-based assays) than glucose-modified and control LDLs. Glucose-modified LDL had more modest increases in net negative charge, aggregation and only significantly lost Arg residues. Under the conditions examined none of the modified LDLs contained significant levels of the protein oxidation products DOPA and o-tyrosine, the lipid oxidation products 7-ketocholesterol and cholesteryl ester hydro(pero)oxides, nor marked depletion of the major antioxidant α-tocopherol or significant radical formation (EPR spectroscopy). Therefore these LDLs were glycated, but not (glyc)oxidised, and so allowed the cellular uptake of glycated LDL, rather than glycoxidised LDL, to be examined. These glycated LDLs had no effect on the cellular viability (assessed by LDH release), cell protein (BCA assay), and cholesterol and cholesteryl ester levels (quantified by reverse-phase HPLC) of endothelial and smooth muscle cells. The glycated LDLs also had no effects on human and mouse macrophage viability, protein and free cholesterol levels. However, exposure of macrophages to some of the glycated LDLs resulted in significant accumulation of cholesteryl esters and apo B. The greatest cellular accumulation of cholesteryl esters was in cells exposed to glycolaldehyde-modified LDL, which occurred in a time- and concentration-dependent manner. Less cholesteryl ester accumulation was observed in cells exposed to methylglyoxal-modified LDL, but some conditions resulted in significantly more cellular cholesteryl esters as compared to control LDLs, unlike glucose-modified LDL. Macrophages endocytosed significantly more apo B from glycolaldehyde-modified LDL labelled with 125I on the apo B, than methylglyoxal-modified 125I-LDL. Apo B from methylglyoxal-modified 125I-LDL was also endocytosed and degraded in greater amounts than control 125I-LDLs, unlike glucose-modified 125I-LDLs. The glycation of LDL by some low-molecular-mass aldehydes have been shown to result in model foam cell formation as characterised by cholesteryl ester and apo B accumulation. This accumulation correlated with increases in net negative charge, aggregation and loss of Lys and Trp residues of the apo B in glycated LDL particles. However, the differences in cellular uptake of glycolaldehyde- versus methylglyoxal-modified LDL were not completely resolved and it is postulated that this may arise from the extent or type of products formed on key amino acid residues, resulting in differential uptake by macrophage scavenger receptors, rather than loss of particular amino acids per se. Therefore these studies provide a potential mechanism to explain the increased atherosclerosis in people with diabetes, and a suitable model to examine the potential inhibition of the effects of glycated LDLs. This could provide potential therapeutic interventions to reduce diabetes-induced atherosclerosis.
|
3 |
Exploration du rôle de TREM-1 dans l'athérosclérose / TREM-1 inhibition reduces atherosclerosisJoffre, Jérémie 25 November 2016 (has links)
Les cellules myéloïdes jouent un rôle majeur dans le développement et les complications de l’athérosclérose. TREM (Triggering Receptor Expressed on Myeloid cells)-1 est un récepteur, exprimé par les cellules myéloïdes, impliqué dans l’amplification de la réponse inflammatoire en réponse à une stimulation de la voie des TLRs. Notre objectif était d’étudier les conséquences de l’inhibition de TREM-1 sur le développement de l’athérosclérose expérimentale.Matériel et résultats : Dans un modèle de souris chimères Ldlr-/- retransplantées avec une moelle de souris Trem-1+/+ ou Trem-1-/-, nous avons montré que la déficience hématopoïétique en Trem-1 induisait une réduction de 42% de la taille des plaques d’athérosclérose au niveau du sinus aortique après 6 semaines de régime gras et une réduction de 60% après 14 semaines. De plus, la déficience hématopoïétique en Trem-1 induisait un phénotype lésionnel plus stable avec une moindre accumulation macrophagique, un centre nécrotique moins volumineux. Ces résultats ont été confirmés dans un modèle de souris ApoE-/-/Trem1-/-. Parallèlement, l’inhibition pharmacologique de TREM-1 par des injections répétées de peptide LR12 induisait une réduction significative de la taille des plaques au niveau du sinus et de l’aorte thoracique chez la souris ApoE-/- sous un régime riche en matières grasses. En utilisant différentes approches in vitro et in vivo, nous avons montré que l’invalidation génique de Trem-1 ou son inhibition pharmacologique induisait une déviation de la réponse immune vers un profil moins inflammatoire, réduisait le recrutement des monocytes non classiques dans la plaque d’athérosclérose et enfin limitait l’endocytose des lipides oxydés en régulant l’expression du CD36. Ces données de modulation de la réponse immune et de l’endocytose des lipides ont été confirmées sur des macrophages humains. Nous avons enfin montré que TREM-1 est exprimé dans des plaques d’athérosclérose humaines essentiellement par les macrophages spumeux. L’expression de TREM-1 est significativement plus importante dans les plaques athéromateuses par rapport aux plaques fibreuses. Conclusion : Nous avons montré que TREM-1 est impliqué dans le développement de l’athérosclérose à différents stades de la maladie, en modulant la réponse immune systémique et l’endocytose des lipides oxydés. L’inhibition de TREM-1 pourrait constituer une nouvelle cible thérapeutique des maladies cardiovasculaires. / Innate immune responses activated through myeloid cells contribute to the initiation, progression and complications of atherosclerosis in experimental models. However, the critical upstream pathways that link innate immune activation to foam cell formation are still poorly identified.Objectives: We hypothesized that activation of TREM (Triggering Receptor Expressed on Myeloid cells)-1 plays a determinant role in macrophage atherogenic responses. Methods and Results: Ldlr-/- mice reconstituted with bone marrow deficient for Trem-1 (Trem-1-/-) showed a strong reduction of atherosclerotic plaque size in both the aortic sinus and the thoraco-abdominal aorta, and were less inflammatory compared to plaques of Trem-1+/+ chimeric mice. Genetic invalidation of Trem-1 led to alteration of monocyte recruitment into atherosclerotic lesions and inhibited Tlr4-initiated pro-inflammatory macrophage responses. Furthermore, we identified a critical role for Trem-1 in the upregulation of Cd36, thereby promoting the formation of inflammatory foam cells. Genetic invalidation of Trem-1 in Apoe-/-/Trem-1-/- mice or pharmacological blockade of Trem-1 in Apoe-/- mice using LR-12 peptide also significantly reduced the development of atherosclerosis throughout the vascular tree, and lessened plaque inflammation. TREM-1 was expressed in human atherosclerotic lesions mainly in lipid-rich areas, with significantly higher levels of expression in atheromatous compared to fibrous plaques. Conclusion: We identify TREM-1 as a major upstream pro-atherogenic receptor. We propose that TREM-1 activation orchestrates monocyte/macrophage pro-inflammatory responses and foam cell formation through coordinated and combined activation of CD36 and TLR4. Blockade of TREM-1 signaling may constitute an attractive novel and double-hit approach for the treatment of atherosclerosis.
|
4 |
Expressão de fragmentos variáveis de cadeia simples anti-LDL eletronegativa (scFv) em Pichia pastoris e seu efeito sobre a formação de células espumosas / Expression of anti-electronegative LDL single-chain fragment variable (scFv) in Pichia pastoris and its effect on foam cells formationKazuma, Soraya Megumi 29 June 2010 (has links)
Os produtos de modificação de lipoproteínas de baixa densidade (LDL) como a subfração eletronegativa [LDL(-)] desempenham um importante papel na progressão da aterosclerose. O acúmulo massivo de LDL modificada captada por macrófagos resulta em células espumosas que liberam mediadores inflamatórios e contribuem para a aterogênese. O scFv (single chain fragment variable) é um fragmento de anticorpo recombinante que contém o sítio completo de ligação ao antígeno. Diante do papel da LDL(-) na aterogênese e da necessidade de novas intervenções terapêuticas que possam inibir o acúmulo de lipídeos em macrófagos, este trabalho objetivou a expressão do scFv anti-LDL(-) 2C7 em Pichia pastoris, bem como a avaliação do efeito deste fragmento de anticorpo sobre a formação de células espumosas em cultura de macrófagos RAW 264.7. O vetor inicial de expressão pPIgLE apresentava como estratégia de detecção e purificação o fusionamento com a proteína A. No entanto, a alta imunogenicidade da proteína A inviabilizaria o estudo da proteína de fusão em cultura de macrófagos, o que determinou a substituição da estratégia de purificação anterior pela cromatografia com resina de níquel através da inserção de hexahistidina na região C-terminal da proteína. A análise de sequenciamento confirmou a presença da inserção e das regiões determinantes de complementariedade. O cassete de expressão com hexahistidina foi inserido no vetor pPIgLE de P. pastoris e transformado na linhagem SMD1168 (Invitrogen®). Testes preliminares de expressão em pequena escala permitiram a análise entre sete clones diferentes, demonstrando uma banda correspondente ao peso molecular de 28 KDa em SDS-PAGE, confirmado por Western Blot. A separação do scFv 2C7 através de resina de níquel obteve uma proteína pura, conforme foi analisado em SDS-PAGE corado com prata. A afinidade do scFv 2C7 a 9 LDL(-) foi confirmada por Dot Blot. O ensaio de captação de LDL(-) demonstrou que o scFv 2C7 foi eficaz na redução de células espumosas e este efeito foi acompanhado pela diminuição na expressão gênica de CD36, TLR-4 e COX-2. Baseado nestes dados, o scFv 2C7 demonstra uma propriedade importante para uma futura intervenção terapêutica para a aterosclerose. / The modification products of low-density lipoprotein (LDL), as the electronegative subfraction [LDL(-)], play an important role in the progression of atherosclerosis. The massive accumulation of modified LDL uptake by macrophages results in foam cells that release inflammatory mediators and contribute to atherogenesis. The scFv (singlechain fragment variable) is a recombinant antibody fragment that contains the complete site antigen-binding. Considering the role of LDL(-) in atherogenesis and the need for new therapeutic interventions that may inhibit the accumulation of lipids in macrophages, this study aimed the expression of anti-LDL(-) 2C7 scFv in Pichia pastoris and the evaluation of the effect of this recombinant antibody fragment on foam cells formation in cultured RAW 264.7 macrophages. The pPIgLE expression initial vector presented as a strategy for detection and purification the fusion with protein A. However, the high immunogenicity of the protein impairs the study of the fusion protein in cultured macrophages, leading to the replacement of the previous strategy of purification by chromatography with nickel resin by inserting hexahistidine tag at the C-terminus of the protein. The sequence analysis confirmed the presence of insertion and the complementary determining regions. The expression cassete with hexahistidine was inserted into the pPIgLE vector of P. pastoris and transformed in the SMD1168 strain (Invitrogen®). Preliminary tests of expression in small-scale allowed the analysis of seven different clones, showing a band corresponding to the molecular weight of 28KDa on SDS-PAGE, confirmed by Western Blot. The separation of 2C7 scFv by the nickel resin yield a pure protein, as it was shown by SDS-PAGE stained with silver. The affinity of 2C7 scFv was confirmed by Dot Blot. The assay of LDL(-) uptake showed that the 2C7 scFv was effective in reducing foam cells and this effect was determined by the decrease in gene expression of CD36, TLR-4 and COX-2. Based on these data, the 2C7 scFv demonstrates an important property for future therapeutic intervention for atherosclerosis
|
5 |
7,8-Dihydroneopterin and its effect on the formation of foam cells.Davies, Sian Patricia Mary January 2015 (has links)
Atherosclerosis (Heart Disease) is an inflammatory disease caused by the formation of plaque within the arterial wall. In response to inflammation, monocytes enter the artery wall, differentiate into macrophages and take up altered low-density-lipoprotein (such as oxidised-LDL). This oxLDL is taken up into the phagocytotic macrophages via the action of the scavenger receptors. If more oxLDL is engulfed than the cell can process, they further differentiate into lipid-loaded foam cells. These are the main cell type found in atherosclerotic plaques. The scavenger receptor CD36 is responsible for 70% of oxLDL uptake by macrophages. Previous studies show that CD36 expression can be down regulated by the antioxidant, 7,8-dihydroneopterin. This research focuses on the effect of CD36 down regulation by 7,8-dihydroneopterin on foam cell formation.
Human macrophages prepared from monocytes purified from human blood were incubated with copper oxidised LDL for up to 48 hours. Macrophage accumulation of the sterols was measured using a high performance chromatograph (HPLC) method developed as part of this project. The HPLC analysis measured: cholesterol, cholesteryl-oleate and -palmitate and 7-ketocholesterol accumulation within human macrophages. A flow cytometry procedure was developed where the strongly adherent macrophages could be lifted from the tissue culture plates before immuno staining for CD36. Effect of incubating macrophages with 7,8-dihydroneopterin on the formation of foam cells was studied by measuring the lipid content by HPLC and flow cytometry measurement of CD36.
HPLC analysis showed non-cytotoxic levels of oxLDL produced a large accumulation of cholesterol and cholesteryl esters in the macrophages. Cholesterol, 7-ketocholesterol and cholesteryl-oleate and -palmitate concentrations in the cells rose significantly over the first 24 hours and stayed at a steady level for the following 24 hours. CD36 levels was further analysed on human macrophages. This study shows that foam cell formation can be measured using human macrophages. 7,8-Dihydroneopterin treatment resulted in a reduction of cholesterol and oxysterol uptake back to basal levels. It also reduced CD36 cell surface expression by a third. These results suggest that even a small reduction in CD36 cell surface expression may have a large effect on foam cell formation. This is another mechanism by which 7,8-dihydroneopterin protects against atherosclerosis developing.
|
6 |
Systems biology analysis of macrophage foam cells finding a novel function for Peroxiredoxin I /Conway, James Patrick. January 2006 (has links)
Thesis (Ph. D.)--Case Western Reserve University, 2006. / [School of Medicine] Department of Physiology and Biophysics. Includes bibliographical references. Available online via OhioLINK's ETD Center.
|
7 |
Expressão de fragmentos variáveis de cadeia simples anti-LDL eletronegativa (scFv) em Pichia pastoris e seu efeito sobre a formação de células espumosas / Expression of anti-electronegative LDL single-chain fragment variable (scFv) in Pichia pastoris and its effect on foam cells formationSoraya Megumi Kazuma 29 June 2010 (has links)
Os produtos de modificação de lipoproteínas de baixa densidade (LDL) como a subfração eletronegativa [LDL(-)] desempenham um importante papel na progressão da aterosclerose. O acúmulo massivo de LDL modificada captada por macrófagos resulta em células espumosas que liberam mediadores inflamatórios e contribuem para a aterogênese. O scFv (single chain fragment variable) é um fragmento de anticorpo recombinante que contém o sítio completo de ligação ao antígeno. Diante do papel da LDL(-) na aterogênese e da necessidade de novas intervenções terapêuticas que possam inibir o acúmulo de lipídeos em macrófagos, este trabalho objetivou a expressão do scFv anti-LDL(-) 2C7 em Pichia pastoris, bem como a avaliação do efeito deste fragmento de anticorpo sobre a formação de células espumosas em cultura de macrófagos RAW 264.7. O vetor inicial de expressão pPIgLE apresentava como estratégia de detecção e purificação o fusionamento com a proteína A. No entanto, a alta imunogenicidade da proteína A inviabilizaria o estudo da proteína de fusão em cultura de macrófagos, o que determinou a substituição da estratégia de purificação anterior pela cromatografia com resina de níquel através da inserção de hexahistidina na região C-terminal da proteína. A análise de sequenciamento confirmou a presença da inserção e das regiões determinantes de complementariedade. O cassete de expressão com hexahistidina foi inserido no vetor pPIgLE de P. pastoris e transformado na linhagem SMD1168 (Invitrogen®). Testes preliminares de expressão em pequena escala permitiram a análise entre sete clones diferentes, demonstrando uma banda correspondente ao peso molecular de 28 KDa em SDS-PAGE, confirmado por Western Blot. A separação do scFv 2C7 através de resina de níquel obteve uma proteína pura, conforme foi analisado em SDS-PAGE corado com prata. A afinidade do scFv 2C7 a 9 LDL(-) foi confirmada por Dot Blot. O ensaio de captação de LDL(-) demonstrou que o scFv 2C7 foi eficaz na redução de células espumosas e este efeito foi acompanhado pela diminuição na expressão gênica de CD36, TLR-4 e COX-2. Baseado nestes dados, o scFv 2C7 demonstra uma propriedade importante para uma futura intervenção terapêutica para a aterosclerose. / The modification products of low-density lipoprotein (LDL), as the electronegative subfraction [LDL(-)], play an important role in the progression of atherosclerosis. The massive accumulation of modified LDL uptake by macrophages results in foam cells that release inflammatory mediators and contribute to atherogenesis. The scFv (singlechain fragment variable) is a recombinant antibody fragment that contains the complete site antigen-binding. Considering the role of LDL(-) in atherogenesis and the need for new therapeutic interventions that may inhibit the accumulation of lipids in macrophages, this study aimed the expression of anti-LDL(-) 2C7 scFv in Pichia pastoris and the evaluation of the effect of this recombinant antibody fragment on foam cells formation in cultured RAW 264.7 macrophages. The pPIgLE expression initial vector presented as a strategy for detection and purification the fusion with protein A. However, the high immunogenicity of the protein impairs the study of the fusion protein in cultured macrophages, leading to the replacement of the previous strategy of purification by chromatography with nickel resin by inserting hexahistidine tag at the C-terminus of the protein. The sequence analysis confirmed the presence of insertion and the complementary determining regions. The expression cassete with hexahistidine was inserted into the pPIgLE vector of P. pastoris and transformed in the SMD1168 strain (Invitrogen®). Preliminary tests of expression in small-scale allowed the analysis of seven different clones, showing a band corresponding to the molecular weight of 28KDa on SDS-PAGE, confirmed by Western Blot. The separation of 2C7 scFv by the nickel resin yield a pure protein, as it was shown by SDS-PAGE stained with silver. The affinity of 2C7 scFv was confirmed by Dot Blot. The assay of LDL(-) uptake showed that the 2C7 scFv was effective in reducing foam cells and this effect was determined by the decrease in gene expression of CD36, TLR-4 and COX-2. Based on these data, the 2C7 scFv demonstrates an important property for future therapeutic intervention for atherosclerosis
|
8 |
Estudo da aterosclerose induzida por diferentestipos de dieta hiperlipídica em coelhos albinos(Oryctolagus cuniculus). / Study of atherosclerosis induced by diferente tipes of hiperlipidic diet in rabbits (Oryctolagus cuniculus)Santos, José André Bernardino dos 14 August 2008 (has links)
The egg yolk chicken and pork lard as compared with other foods, have high
cholesterol. 20 ml of gem shows on average 200 mg cholesterol and 20 ml of lard
average value of 14 mg of cholesterol. Good food for experiences concerning
cholesterol, are low cost compared them with cholesterol powder. Method: We used
rabbits of New Zealand (n = 42) adults from 7 to 8 months of age divided into groups
of 4: control group diet with 200 g and water ad libitum (G1), the group treated with 1
g of cholesterol (G2); group treated with 20 ml egg yolk (G3); group treated with 20
ml of lard (G4); group (G5) treated with 40 ml of yolk and the group (G6) treated with
40 ml of lard. All groups were fed during the period of 100 days with the aim of
verifying which of the diet is best for induction of atherosclerosis. The blood collection
for the dosages of the lipid profile of animals occurred at times 0, 30, 60 and 100
days. At the end of the trial period, the animals were subjected to euthanasia.
Segments of the aortic arch, the right carotid artery and right femoral artery were
collected for analysis histological. Results: As expected the group G1 not noticed
amendment, the group G2 training light of atherosclerosis, the group returned G3
significant increase (p <0,05) in total cholesterol levels, the group G4 were not
identified histological changes and G5 and G6 is not adapted the diet administered.
By microscopic examination, were observed foam cells in the aortic arch, and femoral
and carotid thickening of endothelium in the group G3 so significant comparing them
with the G2. Conclusion: The diet enriched with egg yolk, chicken is the best option
for formation of foam cells and thickening of endothelium, is practical and low cost for
research on cholesterol and atherosclerosis. / A gema de ovo de galinha e a banha do porco, em relação aos outros alimentos, têm
alto índice de colesterol total. 20 ml de gema apresenta em média 200 mg de
colesterol total e 20 ml de banha valor médio de 14 mg de colesterol total. São bons
alimentos para experiências referentes à colesterolemia, são de baixo custo
comparando-os com colesterol puro. Métodos: Foram utilizados coelhos da Nova
Zelândia (n=42) adultos entre 7 a 8 meses de idade divididos em grupos de 4: grupo
controle com ração 200 g e água ad libitum (G1); o grupo tratado com 1 g de
colesterol (G2); grupo tratado com 20 ml gema de ovo (G3); grupo tratado com 20 ml
de banha (G4); grupo (G5) tratado com 40 ml de gema e o grupo (G6) tratado com
40 ml de banha. Todos os grupos foram alimentados durante o período de 100 dias
tendo como objetivo verificar qual das dietas é melhor para indução da
aterosclerose. A coleta de sangue para as dosagens do perfil lipídico dos animais
aconteceram nos momentos 0, 30, 60 e 100 dias. Ao término do período
experimental, os animais foram submetidos à eutanásia. Segmentos do arco aórtico,
da artéria carótida direita e artéria femoral direita foram coletados para análise
histológica. Resultados: Como esperado o grupo G1 não observou alteração, o
grupo G2 formação leve de aterosclerose, o grupo G3 obteve aumento significante
(p<0,05) nos níveis de colesterol total, o grupo G4 não foram identificada alterações
histológicas e o G5 e G6 não se adaptaram a dieta administrada. Ao exame
microscópico, foram observadas células espumosas no arco aórtico, femoral e
carótida e espessamento de endotélio no grupo G3 de forma significante
comparando-os ao G2. Conclusão: A dieta enriquecida com gema de ovo de
galinha é a melhor opção para formação de células espumosas e espessamento de
endotélio, é prática e de baixo custo para pesquisas com colesterolemia e
aterosclerose.
|
9 |
Atherosclerosis-Related Functions of C-Reactive ProteinAgrawal, Alok, Hammond, David J., Singh, Sanjay K. 01 January 2010 (has links)
C-reactive protein (CRP) is secreted by hepatocytes as a pentameric molecule made up of identical monomers, circulates in the plasma as pentamers, and localizes in atherosclerotic lesions. In some cases, localized CRP was detected by using monoclonal antibodies that did not react with native pentameric CRP but were specific for isolated monomeric CRP. It has been reported that, once CRP is bound to certain ligands, the pentameric structure of CRP is altered so that it can dissociate into monomers. Accordingly, the monomeric CRP found in atherosclerotic lesions may be a stationary, ligand-bound, by-product of a ligand-binding function of CRP. CRP binds to modified forms of low-density lipoprotein (LDL). The binding of CRP to oxidized LDL requires acidic pH conditions; the binding at physiological pH is controversial. The binding of CRP to enzymatically-modified LDL occurs at physiological pH; however, the binding is enhanced at acidic pH. Using enzymatically-modified LDL, CRP has been shown to prevent the formation of enzymatically-modified LDL-loaded macrophage foam cells. CRP is neither pro-atherogenic nor atheroprotective in ApoE-/-and ApoB100/100Ldlr-/-murine models of atherosclerosis, except in one study where CRP was found to be slightly atheroprotective in ApoB100/100Ldlr-/-mice. The reasons for the ineffectiveness of human CRP in murine models of atherosclerosis are not defined. It is possible that an inflammatory environment, such as those characterized by acidic pH, is needed for efficient interaction between CRP and atherogenic LDL during the development of atherosclerosis and to observe the possible atheroprotective function of CRP in animal models.
|
10 |
Vésicules extracellulaires et régulation de la réponse inflammatoire dans les pathologies cardiovasculaires / Extracellular vesicles and inflammatory regulation in cardiovascular diseasesYin, Min 30 November 2015 (has links)
Les vésicules extracellulaires telles que les microvésicules et les exosomes sont libérées lors de l’apoptose ou de l’activation cellulaire. Ce sont des médiateurs importants dans la communication intercellulaire, suggérant que ces vésicules pourraient jouer un rôle physiopathologique, en particulier dans les maladies cardiovasculaires. L'athérosclérose est une maladie inflammatoire chronique de la paroi artérielle qui résulte de l’interaction entre les lipoprotéines, les cellules inflammatoires, et les cellules vasculaires. L'infarctus du myocarde est une complication aiguë et grave de l'athérosclérose. La réaction inflammatoire post-infarctus joue un rôle central dans la formation de néovaisseaux sanguins et la cicatrisation. Cependant, les mécanismes de l’inflammation sont encore mal connus dans ces pathologies. Mon travail de thèse a porté sur les effets des vésicules extracellulaires isolées de tissus pathologiques sur les cellules inflammatoires. Nous avons montré dans un premier travail que les microvésicules s’accumulant dans les lésions d’athérosclérose humaines contribuent à la surcharge en cholestérol et en triglycérides des macrophages et facilitent la formation de cellules spumeuses. L’accumulation des lipides intracellulaires induite par ces microvésicules est contrebalancée par une augmentation de l’efflux du cholestérol associée à une activation d’ABCA1. Dans un deuxième travail, nous avons examiné les effets des vésicules produites dans le cœur post-infarctus sur la réponse inflammatoire. Nos résultats montrent : 1- une augmentation de la libération in situ des microvésicules majoritairement d’origine cardiomyocytaire et des exosomes 15 heures après infarctus ; 2- la stimulation de la production de VEGF monocytaire par les vésicules extracellulaires ; 3- l’incapacité en ce qui concerne les vésicules isolées de cœur diabétique infarci à reproduire cet effet sur les monocytes des souris contrôles. Afin de clarifier les déterminants de l’angiogenèse post-ischémique, nous avons également étudié les profils de miARNs des vésicules contrôles et diabétiques. Après infarctus du myocarde, l’expression de miR-126-3p et de miR-92a-3p est significativement diminuée dans les vésicules diabétiques en comparaison avec les vésicules contrôles. Par ailleurs, nous avons observé une augmentation de miR-126-3p et de miR-92a-3p respectivement dans les microvésicules et les exosomes chez les souris contrôles post-infarctus. En conclusion, ce travail apporte des éléments nouveaux sur les fonctions des vésicules extracellulaires générées localement dans les tissus inflammatoires, en particulier leur capacité à promouvoir la transformation des macrophages en cellules spumeuses dans la plaque. Par ailleurs, les vésicules isolées du cœur ischémique pourraient favoriser l’angiogenèse post-infarctus en stimulant la production de VEGF monocytaire. La disparition de cet effet bénéfique dans le diabète pourrait être associée à des modifications d’adressage des miARNs dans les vésicules extracellulaires au cours de cette pathologie. / Extracellular vesicles, such as microvesicles and exosomes, are released during cell apoptosis or activation. They are important mediators of intercellular communication, suggesting that these vesicles could play a pathophysiological role, especially in cardiovascular diseases. Atherosclerosis is a chronic inflammatory disease of the arterial wall which results from the interaction between lipoproteins, inflammatory cells, and vascular cells. Myocardial infarction is an acute and severe complication of atherosclerosis. The postinfarction inflammatory response plays a central role in the formation of new blood vessels and scarring. However, the mechanisms of inflammation are still poorly known in these pathologies. My thesis concerned the effects of extracellular vesicles isolated from pathological tissues on inflammatory cells. We showed in the first work that microvesicles accumulating in human atherosclerotic lesions contribute to cholesterol and triglyceride overload in macrophages and facilitate foam cell formation. The accumulation of the intracellular lipids induced by those microvesicles is offset by an increase in cholesterol efflux associated with activation of ABCA1. In the second study, we examined the effect of vesicles produced in the infarcted heart on the inflammatory response. Our results showed : 1- an increased release in situ of microvesicles mostly of cardiomyocyte origin and exosomes 15 hours after infarction ; 2- the stimulation of monocyte VEGF production by extracellular vesicles ; 3- the incapacity of diabetic vesicles isolated from infarcted heart to reproduce that effect on control mice monocytes. In order to clarify the determinants of postischemic angiogenesis, we also studied miRNA profiles of control and diabetic vesicles. After myocardial infarction, the expression level of miR-126-3p and miR-92a-3p was significantly decreased in diabetic vesicles compared to control vesicles. Furthermore, we observed an increased expression of miR-126-3p and miR-92a-3p respectively in the microvesicles and the exosomes isolated from control mice heart after myocardial infarction. In conclusion, this work provides new information on the functions of extracellular vesicles locally generated in inflamed tissues, particularly in promoting macrophage transformation into foam cells in the atherosclerotic plaque. Furthermore, vesicles isolated from ischemic heart could enhance postinfarction angiogenesis by stimulating monocyte VEGF production. The loss of this beneficial effect in diabetes may be associated with changes of miRNA cargo in extracellular vesicles in this pathology.
|
Page generated in 1.336 seconds